BR112015008139A2 - formulação de forma de dosagem sólida de desintegração rápida compreendendo carbonato de cálcio funcionalizado e método de fabricação dos mesmos - Google Patents

formulação de forma de dosagem sólida de desintegração rápida compreendendo carbonato de cálcio funcionalizado e método de fabricação dos mesmos

Info

Publication number
BR112015008139A2
BR112015008139A2 BR112015008139A BR112015008139A BR112015008139A2 BR 112015008139 A2 BR112015008139 A2 BR 112015008139A2 BR 112015008139 A BR112015008139 A BR 112015008139A BR 112015008139 A BR112015008139 A BR 112015008139A BR 112015008139 A2 BR112015008139 A2 BR 112015008139A2
Authority
BR
Brazil
Prior art keywords
calcium carbonate
dosage form
solid dosage
manufacture
functionalized
Prior art date
Application number
BR112015008139A
Other languages
English (en)
Other versions
BR112015008139B1 (pt
Inventor
E Gerard Daniel
Schoelkopf Joachim
Huwyler Jörg
Puchkov Maxim
A C Gane Patrick
Alles Rainer
Strinimann Tanja
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022552&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015008139(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of BR112015008139A2 publication Critical patent/BR112015008139A2/pt
Publication of BR112015008139B1 publication Critical patent/BR112015008139B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/006—Pressing and sintering powders, granules or fibres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/772—Articles characterised by their shape and not otherwise provided for

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Geology (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

resumo “formulação de forma de dosagem sólida de desintegração rápida compreendendo carbonato de cálcio funcionalizado e método de fabricação dos mesmos” forma de dosagem oral de desintegração rápida compreendendo carbonato de cálcio natural ou sintético funcionalizado, pelo menos um ingrediente ativo, pelo menos, um desintegrante, em que o referido carbonato de cálcio natural ou sintético funcionalizado é um produto de reação de carbonato de cálcio natural ou sintético com dióxido de carbono e um ou mais ácidos, em que o dióxido de carbono é formado in situ pelo tratamento com ácido e/ou é fornecido a partir de uma fonte externa, e em que o comprimido se dissolve em menos de 20 segundos, quando introduzido em um ambiente aquoso.
BR112015008139-8A 2012-10-12 2013-10-10 Formulação de forma de dosagem sólida de desintegração rápida compreendendo carbonato de cálcio funcionalizado e método de fabricação dos mesmos BR112015008139B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12188344.1 2012-10-12
EP12188344.1A EP2719373B1 (en) 2012-10-12 2012-10-12 Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US201261713671P 2012-10-15 2012-10-15
US61/713,671 2012-10-15
PCT/EP2013/071169 WO2014057038A1 (en) 2012-10-12 2013-10-10 Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture

Publications (2)

Publication Number Publication Date
BR112015008139A2 true BR112015008139A2 (pt) 2017-07-04
BR112015008139B1 BR112015008139B1 (pt) 2022-06-07

Family

ID=47022552

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015008139-8A BR112015008139B1 (pt) 2012-10-12 2013-10-10 Formulação de forma de dosagem sólida de desintegração rápida compreendendo carbonato de cálcio funcionalizado e método de fabricação dos mesmos

Country Status (27)

Country Link
US (1) US20150283082A1 (pt)
EP (2) EP2719373B1 (pt)
JP (1) JP6196676B2 (pt)
KR (1) KR101740835B1 (pt)
CN (2) CN104768531A (pt)
AR (1) AR092957A1 (pt)
AU (1) AU2013328639B2 (pt)
BR (1) BR112015008139B1 (pt)
CA (1) CA2884912C (pt)
CL (1) CL2015000893A1 (pt)
CO (1) CO7350657A2 (pt)
DK (2) DK2719373T3 (pt)
ES (2) ES2628371T3 (pt)
HR (1) HRP20191082T1 (pt)
HU (1) HUE044281T2 (pt)
IL (1) IL237766B (pt)
MX (1) MX369779B (pt)
MY (1) MY174635A (pt)
PL (2) PL2719373T3 (pt)
PT (1) PT2916816T (pt)
RU (2) RU2018127317A (pt)
SG (1) SG11201502290SA (pt)
SI (2) SI2719373T1 (pt)
TR (1) TR201909173T4 (pt)
TW (1) TWI583387B (pt)
UY (1) UY35071A (pt)
WO (1) WO2014057038A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2883573B2 (en) 2013-12-13 2020-10-28 Omya International AG Abrasive cleaning composition
US10238598B2 (en) 2013-12-16 2019-03-26 The University Of British Columbia Self-fueled particles for propulsion through flowing aqueous fluids
EP2921173A1 (en) * 2014-03-21 2015-09-23 Omya International AG Surface-reacted calcium carbonate for desensitizing teeth
EP2949708B1 (en) 2014-05-30 2018-04-04 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
CN106414332B (zh) 2014-05-30 2018-12-21 欧米亚国际集团 用于制造包含表面反应的碳酸钙的颗粒的方法
EP2957603A1 (en) 2014-06-20 2015-12-23 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) * 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275946A1 (en) * 2016-07-25 2018-01-31 Omya International AG Post treatment of surface-reacted calcium carbonate with different functional cations
EP3275537A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3594289A1 (en) * 2018-07-13 2020-01-15 Omya International AG Surface-reacted calcium carbonate for stabilizing mint oil
EP3682901A1 (en) 2019-01-21 2020-07-22 Omya International AG High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
EP3622966A1 (en) 2018-09-17 2020-03-18 Omya International AG High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
MX2021001562A (es) * 2018-09-17 2021-06-08 Omya Int Ag Excipiente de alto rendimiento que comprende celulosa microcristalina co-procesada y carbonato de calcio reaccionado en superficie.
CN109749745A (zh) * 2018-12-21 2019-05-14 西北农林科技大学 一种利用土体固化溶液加固土体的方法
US11113797B1 (en) 2019-08-19 2021-09-07 Snap Inc. Passive flash imaging
US20230174786A1 (en) 2020-04-28 2023-06-08 Omya International Application Method for the production of free-flowing granules
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
BR112022022264A2 (pt) * 2020-05-28 2022-12-20 Unilever Ip Holdings B V Tablete para formar uma composição para lavagem de louças líquida e método para formar um líquido para lavagem de louças manual

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
US4650699A (en) * 1983-04-18 1987-03-17 Sermetel Thixotropic alumina coating compositions, parts and methods
US6066337A (en) 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US5595761A (en) 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5635210A (en) 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
US20050244493A1 (en) * 2004-04-30 2005-11-03 Withiam Michael C Rapidly disintegrating tablets comprising calcium carbonate
PL2070991T3 (pl) 2007-12-12 2011-02-28 Omya Int Ag Sposób wytwarzania strącanego węglanu wapnia o powierzchni zmodyfikowanej chemicznie
JP5490691B2 (ja) * 2008-06-12 2014-05-14 株式会社三和化学研究所 炭酸カルシウム含有速崩壊性製剤
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
EP2198857A1 (en) * 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
EP2210591B1 (en) * 2009-01-26 2016-03-30 Shin-Etsu Chemical Co., Ltd. Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
JP4562797B1 (ja) * 2009-05-29 2010-10-13 マイラン製薬株式会社 沈降炭酸カルシウムを有効成分とする口腔内崩壊錠
PL2264108T3 (pl) 2009-06-15 2012-07-31 Omya Int Ag Sposób wytwarzania przereagowanego powierzchniowo węglanu wapnia, z wykorzystaniem słabego kwasu
PT2377900E (pt) * 2010-04-16 2013-11-07 Omya Int Ag Processo para preparar um material mineral com superfície modificada seus produtos resultantes e suas utilizações

Also Published As

Publication number Publication date
SG11201502290SA (en) 2015-04-29
MX369779B (es) 2019-11-21
SI2719373T1 (sl) 2017-07-31
RU2018127317A3 (pt) 2022-03-24
HUE044281T2 (hu) 2019-10-28
DK2916816T3 (da) 2019-07-01
IL237766B (en) 2021-07-29
RU2015115916A (ru) 2016-11-27
ES2628371T3 (es) 2017-08-02
CN104768531A (zh) 2015-07-08
DK2719373T3 (en) 2017-07-03
TWI583387B (zh) 2017-05-21
EP2719373A1 (en) 2014-04-16
KR101740835B1 (ko) 2017-05-26
HRP20191082T1 (hr) 2019-10-18
BR112015008139B1 (pt) 2022-06-07
CN110742867A (zh) 2020-02-04
RU2676087C2 (ru) 2018-12-26
AU2013328639A1 (en) 2015-04-02
ES2732841T3 (es) 2019-11-26
IL237766A0 (en) 2015-05-31
AU2013328639A8 (en) 2015-05-14
US20150283082A1 (en) 2015-10-08
SI2916816T1 (sl) 2019-08-30
KR20150063444A (ko) 2015-06-09
PL2916816T3 (pl) 2019-09-30
RU2018127317A (ru) 2019-03-14
MY174635A (en) 2020-05-04
PT2916816T (pt) 2019-06-28
TR201909173T4 (tr) 2019-07-22
AR092957A1 (es) 2015-05-06
CL2015000893A1 (es) 2015-08-28
JP6196676B2 (ja) 2017-09-13
UY35071A (es) 2014-05-30
JP2015533140A (ja) 2015-11-19
CA2884912A1 (en) 2014-04-17
PL2719373T3 (pl) 2017-10-31
EP2916816B1 (en) 2019-03-27
MX2015004234A (es) 2015-06-10
WO2014057038A1 (en) 2014-04-17
EP2719373B1 (en) 2017-04-19
TW201438722A (zh) 2014-10-16
CA2884912C (en) 2018-01-02
CO7350657A2 (es) 2015-08-10
AU2013328639B2 (en) 2016-09-15
EP2916816A1 (en) 2015-09-16

Similar Documents

Publication Publication Date Title
BR112015008139A2 (pt) formulação de forma de dosagem sólida de desintegração rápida compreendendo carbonato de cálcio funcionalizado e método de fabricação dos mesmos
BR112015008054A2 (pt) formulação de fármaco de retenção gástrica e sistemas de distribuição e seu método de preparação usando carbonato de cálcio funcionalizado
BR112017005780A2 (pt) ?uso de um carbonato de cálcio reagido na superfície como agente antiaglomerante, métodos para controlar, reduzir ou evitar aglomeração de uma composição particulada e para produzir uma composição, e, composição?
MX2017008937A (es) Carbonato de calcio tratado en la superficie con estabilidad mejorada en ambientes con un ph de 4.5 a 7.
BR112015028313A2 (pt) um sistema de preparação de bebidas, uma cápsula e um método para formação de uma bebida
BR112014004460A2 (pt) material polimérico para um recipiente isolado
MX346058B (es) Metodo de alarma gradual para monitores de pacientes.
CL2018001420A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853)
MX2013010362A (es) Una composicion estable de hoc1, procedimientos para su produccion y usos de los mismos.
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
PE20140255A1 (es) Tableta dispersable en forma oral
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
BR112013020816A2 (pt) substrato sólido poroso desintegrável para aplicações para cuidados pessoais com a saúde
BR112012027794A2 (pt) tablete entérico
BR112014031934A8 (pt) Método com base em euglobulina para determinar a atividade biológica de defibrotide
BR112014030680A2 (pt) forma de dosagem efervescente
WO2015086838A3 (en) A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
EP2591774A4 (en) MELTING TABLET
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
BR112015028992A2 (pt) método para a produção de um composto de piridazina
BR112015010119A2 (pt) composição farmacêutica que contém um inibidor de ace e um bloqueador do canal de cálcio
BR112016024574A2 (pt) granulado de dissolução rápida
BR112015014739A2 (pt) carbonato hidróxido de magnésio como excipiente em preparações farmacêuticas tendo liberação melhorada do ingrediente ativo
BR112012024576A2 (pt) composição farmacêutica de liberação modificada compreendendo desvenlafaxina ou sais da mesma e processo para preparação da dita composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/10/2013, OBSERVADAS AS CONDICOES LEGAIS